Blend ratio 5 : 1 : 1 (GHK-Cu : TB-500 : BPC-157) GHK-Cu dominant 70 mg total per vial: 50 mg GHK-Cu, 10 mg TB-500, and 10 mg BPC-157
In practice, even well-designed studies can encounter issues, not because data are absent, but because they are fragmented or disconnected from the broader study context
not approved for human therapeutic or veterinary use
However, increases in hormone levels do not always translate into dramatic real-world muscle gains, especially in already healthy, resistance-trained individuals
Nonetheless, numerous inquiries remain unanswered
Indeed, it has been reported that depending on its temporal expression during the angiogenic process it can exert pro- or anti-angiogenic effects by regulating the expression of VEGFR2 [212]